BGLAIVE Trademark

Trademark Overview

On Friday, September 26, 2008, a trademark application was filed for BGLAIVE with the United States Patent and Trademark Office. The USPTO has given the BGLAIVE trademark a serial number of 79062978. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 26, 2018. This trademark is owned by Laboratoire Français; du Fractionnementet des Biotechnologies. The BGLAIVE trademark is filed in the Pharmaceutical Products category with the following description:

Recombinant monoclonal antibody directed against CD 20, for disease testing and medical treatment use
bglaive

General Information

Serial Number79062978
Word MarkBGLAIVE
Filing DateFriday, September 26, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 26, 2018
Registration Number3655045
Registration DateTuesday, July 14, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2009

Trademark Statements

Goods and ServicesRecombinant monoclonal antibody directed against CD 20, for disease testing and medical treatment use
Translation of Words in MarkThe wording "BGLAIVE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 19, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLaboratoire Français; du Fractionnementet des Biotechnologies
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameLaboratoire Français; du Fractionnementet des Biotechnologies
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameLaboratoire Français; du Fractionnementet des Biotechnologies
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Wednesday, May 22, 2019UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, April 26, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, April 26, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 7, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, January 18, 2017GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, January 18, 2017GENERIC MADRID TRANSACTION CREATED
Wednesday, October 19, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 19, 2016CANCELLED SECTION 71
Thursday, March 26, 2015NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 21, 2014NEW REPRESENTATIVE AT IB RECEIVED
Sunday, March 31, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 27, 2009FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 27, 2009FINAL DISPOSITION PROCESSED
Thursday, October 15, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 14, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, April 28, 2009PUBLISHED FOR OPPOSITION
Friday, April 24, 2009UNDELIVERABLE MAIL - NO ACTION TAKEN
Wednesday, April 8, 2009NOTICE OF PUBLICATION
Thursday, March 26, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 20, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 26, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 26, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 26, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 25, 2009ASSIGNED TO LIE
Tuesday, February 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 24, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 6, 2009REFUSAL PROCESSED BY IB
Tuesday, January 13, 2009APPLICATION FILING RECEIPT MAILED
Friday, January 9, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 9, 2009REFUSAL PROCESSED BY MPU
Friday, January 9, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 8, 2009NON-FINAL ACTION WRITTEN
Wednesday, January 7, 2009ASSIGNED TO EXAMINER
Wednesday, January 7, 2009NEW APPLICATION ENTERED IN TRAM
Tuesday, January 6, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

bglaive testing medical treatment disease against monoclonal antibody directed recombinant